Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 2 1

Status

Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Carcinoma, Hepatocellular 1

Interventions

anlotinib 5Cisplatin 5Carboplatin 5Immune Checkpoint Inhibitors 4tislelizumab 3sintilimab 3lenvatinib 3Oxaliplatin 3Fluorouracil 3Capecitabine 3Bevacizumab 3venetoclax 2Rosuvastatin Calcium 2Prednisone 2Megestrol Acetate 2Leucovorin 2Gemcitabine 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Aspirin 2zanubrutinib 1xiaojin wan 1trastuzumab deruxtecan 1trametinib 1toripalimab 1tocilizumab 1testosterone 17 beta-cypionate 1tenofovir alafenamide 1telitacicept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Hepatectomy × Clear all
NCT06311916 2024-03-15

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Tongji Hospital

Phase 4 Not yet recruiting
312 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡